Hematology (non-oncology)

REACH is an experienced thought leader in the hematology space. Our team has conducted research across many hematologic diseases, both rare and non-rare.

DISEASES WE COVER

Hematology has evolved from life-threatening diagnoses due to lack of treatments to the availability of many effective treatments for both genetic and immune driven hematology conditions. Current hematology dynamics the REACH team is tracking include:

  • Real-world experience with groundbreaking gene editing and transfer therapies (e.g., Vertex/CRISPR Therapeutics’ Casgevy and bluebird bio’s Lyfgenia for Sickle Cell Disease; CSL Behring’s Hemgenix for Hemophilia B, BioMarin’s Roctavian for Hemophilia A)
  • Novel therapies for immunohematology disorders
  • Competitive dynamics in increasingly crowded hematology markets such as Hemophilia and Paroxysmal Nocturnal Hemoglobinuria (PNH)
See our rare hematology solutions

Search Hematology diseases we cover

Disease
Acquired Aplastic Anemia
Acquired Aplastic Anemia
Castleman Disease
Castleman Disease
Cold Agglutinin Disease
Cold Agglutinin Disease
Hemophilia A
Hemophilia A
Hemophilia B
Hemophilia B
Immune Thrombocytopenic Purpura
Immune Thrombocytopenic Purpura
Paroxysmal Nocturnal Hemoglobinuria
Paroxysmal Nocturnal Hemoglobinuria
Pernicious Anemia
Pernicious Anemia
POEMS Syndrome
POEMS Syndrome
Primary Pure Red Cell Aplasia
Primary Pure Red Cell Aplasia
Sickle Cell Disease
Sickle Cell Disease
Thrombotic Thrombocytopenic Purpura
Thrombotic Thrombocytopenic Purpura
VEXAS Syndrome
VEXAS Syndrome
Von Willebrand Disease
Von Willebrand Disease
Warm Autoimmune Hemolytic Anemia
Warm Autoimmune Hemolytic Anemia
Don’t see your disease of interest? Don’t worry! Our experienced team can provide market research support for any rare disease. Reach out to learn how we can help.
Disease
Acquired Aplastic Anemia
Acquired Aplastic Anemia
Castleman Disease
Castleman Disease
Cold Agglutinin Disease
Cold Agglutinin Disease
Don’t see your disease of interest? Don’t worry! Our experienced team can provide market research support for any rare disease. Reach out to learn how we can help.
Browse contacts:
1 2 3 … 5

Schedule a hematology demo with our team

OUR SOLUTIONS

Market Landscape Assessment

MarketVue® reports capture the current and anticipated future state of any rare hematology market

Learn More

Epidemiology

EpiVue® reports quantify prevalence, diagnosis, treatment rates and patient segments for rare hematological conditions

Learn More

Indication Prioritization

MarketSheet® single-sheet market primers for any hematology disease allow easy comparison across the hematology therapy area

Learn More

Custom Rapid Insights

Fast turnaround primary market research for a focused set of questions for hematologists or payers

Learn More

Reach out to our team to learn more about our capabilities and view sample reports.

Contact us